期刊文献+

白术内酯3抗血小板作用及其机制 被引量:29

Inhibitory effects of atractylenolide 3 on platelet and its mechanism
下载PDF
导出
摘要 目的观察白术内酯3在体外对人血小板活化的影响,并探讨其可能的分子机制。方法通过体外血小板聚集实验,采用比浊法测定不同浓度白术内酯3对血栓烷类似物(U46619)诱发的人血小板聚集的影响;运用荧光素酶检测白术内酯3对血小板ATP分泌的影响;运用Western印迹法检测分子细胞外调节蛋白激酶(Erk1/2)、蛋白激酶B(Akt473)的磷酸化水平。结果白术内酯3可抑制U46619诱导下人血小板的体外聚集,其抑制效果具有浓度依赖性,各个浓度的实验组与DMSO对照组相比较,差异具有统计学意义(P<0.01);白术内酯3可抑制人血小板在U46619诱导下ATP的分泌且具有浓度依赖性,各个浓度的实验组与DMSO对照组相比较,差异具有统计学意义(P<0.01);经白术内酯3处理后人血小板活化信号通路中的Akt473、Erk1/2分子的磷酸化水平明显降低;与DMSO对照组相比,其差异具有统计学意义(P<0.01)。结论白术内酯3对U46619诱导的人血小板聚集及分泌均能产生显著抑制作用,并影响其血小板活化过程中MAPK和PI3K-Akt信号通路。提示白术内酯3是一种有效的抗血小板化合物,有望成为新型抗血小板药物。 Objective To study the effects of atractylenolide 3 on human platelet in vitro and explore the underlying mechanism. Methods The effects of atractylenolide 3 on human platelet aggregation induced by thrombus alkane analogues(U46619)was tested by turbidimetry in vitro. ATP secretion weas detected by luciferase detection,and the phosphorylation levels of Erk and Akt were detected by Western blotting. Results Atractylenolide 3 diminished U46619-induced human platelet aggregation in concentration dependence. Compared with DMSO control group,the inhibitory rate were significant increased in each experiment group(P0.01). Atractylenolide 3 inhibited adenosine triphosphate(ATP)secreted by human platclet in concentration dependence. Compared with the DMSO control group,the inhibitory rate were significant increased in each experiment group(P0.01),and the levels of phospho-Akt(Ser473)and phospho-Erk1/2 were significant downregulated in the presence of atractylenolide 3 in each experiment group(P0.01). Conclusion Atractylenolide 3 exhibits a concentration-dependent inhibitory effect on human platelet aggregation and secretion induced by U46619. Also,it regulated the MAPK and PI3K-Akt signaling pathways. These results show that atractylenolide 3 is an effective antiplatelet compound,may serve as new antithrombotic drugs.
出处 《国际药学研究杂志》 CAS CSCD 北大核心 2016年第3期514-517,共4页 Journal of International Pharmaceutical Research
基金 上海交通大学医学院附属第三人民医院基金资助(2015-002)
关键词 白术内酯3 血小板 血栓 心血管疾病 atractylenolide 3 platelet thrombus cardiovascular disease
  • 相关文献

参考文献15

  • 1Liu L,Li J,Zhang Y,et al. Salvianolic acid B inhibits platelets as a P2Y12 antagonist and PDE inhibitor: evidence from clinic. 被引量:1
  • 2Maione F,De Feo V,Caiazzo E,et al. Tanshinone ⅡA, a major component of Salvia miltiorrhiza Bunge, inhibits platelet activation via Erk-2 signaling pathway [J]. J Ethnopharmacol,2014,155(2):1236-1242. 被引量:1
  • 3Ge J,Wang YW,Lu XC, et al. Determination of atractylenolide Ⅱin rat plasma by reversed-phase high-performance liquid chro- to laboratory [J]. Thromb Res,2014,134(4):866-876. matography [J]. Biomed Chromatogr,2007,21(3):299-303. 被引量:1
  • 4Kang TH,Bang JY,Kim MH, et al. Atractylenolide Ⅲ, a sesquiterpenoid, induces apoptosis in human lung carcinoma A549 cells via mitochondria-mediated death pathway [J]. Food Chem Toxicol,2011,49(2):514-519. 被引量:1
  • 5Weng Z,Li D,Zhang L, et al. PTEN regulates collagen-induced platelet activation [J]. Blood,2010,116(14):2579-2581. 被引量:1
  • 6Liu J,Jackson CW,Gruppo RA, et al. The beta3 subunit of the integrin alphaⅡbbeta3 regulates alphaⅡb-mediated outside-in signaling [J]. Blood,2005,105(11):4345-4352. 被引量:1
  • 7Flevaris P,Li Z,Zhang G,et al. Two distinct roles of mitogen-activated protein kinases in platelets and a novel Rac1-MAPK-dependent integrin outside-in retractile signaling pathway [J]. Blood,2009,113(4):893-901. 被引量:1
  • 8Liu J,Fitzgerald ME,Berndt MC, et al. Bruton tyrosine kinase is essential for botrocetin/VWF-induced signaling and GPⅠb-dependent thrombus formation in vivo[J]. Blood,2006,108(8):2596-2603. 被引量:1
  • 9赵桂芝,洪学智,戴诗文,寿旦,王绪平.白术内酯的药理学研究进展[J].中国药房,2009,20(3):230-231. 被引量:17
  • 10彭腾,李鸿翔,邓赟,邱建平,贺钢民,范静骞.白术内酯类成分及其药理作用研究进展[J].中国药房,2012,23(39):3732-3734. 被引量:49

二级参考文献38

共引文献121

同被引文献550

引证文献29

二级引证文献846

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部